Increased blood glucose variability during therapeutic hypothermia and outcome after cardiac arrest*

Objective:Hypothermia impairs blood glucose homeostasis and insulin sensitivity. However, the impact of therapeutic hypothermia on blood glucose levels and insulin requirements is unknown. We analyzed blood glucose variability during therapeutic hypothermia in patients with coma after cardiac arrest and examined its impact on outcome. Design:Prospective observational study. Setting:Two university hospital medical/surgical intensive care units. Patients:Comatose cardiac arrest patients treated with therapeutic hypothermia (33°C, 24 hrs). Interventions:Insulin therapy (blood glucose target 6–8 mmol/L [110–150 mg/dL]), according to a written algorithm, with nurse-driven adjustment of insulin dose. Measurements and Main Results:Two-hundred and twenty patients (median age 61 yrs, median time to return of spontaneous circulation 20 min) were studied. Two time periods, comparable in duration, were categorized: therapeutic hypothermia (stable maintenance phase) and normothermia (after rewarming). Blood glucose variability was defined as the difference between maximum and minimum blood glucose concentration during each time period. Mean blood glucose (8.3 ± 2.3 vs. 7.1 ± 1.3 mmol/L), blood glucose variability (5.7 ± 3.9 vs. 3.7 ± 3.6 mmol/L), and insulin dose (2 ± 2 vs. 1 ± 1 U/h) were higher during therapeutic hypothermia compared to normothermia (all p < .001). Higher mean blood glucose (7.9 ± 1.8 mmol/L in survivors vs. 8.7 ± 2.6 mmol/L in nonsurvivors, p = .02) and increased blood glucose variability (4.9 ± 3.5 vs. 6.5 ± 4.1 mmol/L, p = .003) during therapeutic hypothermia were associated with mortality. After adjusting for time to return of spontaneous circulation, initial arrest rhythm, and cardiac arrest etiology, increased blood glucose variability during therapeutic hypothermia, but not mean blood glucose level, was an independent predictor of inhospital mortality (odds ratio for death 1.10 [confidence interval 1.02–1.19], p = .016). Conclusions:Mild therapeutic hypothermia is associated with higher blood glucose levels, increased blood glucose variability, and greater insulin requirements compared to the postrewarming normothermic phase. Increased blood glucose variability during therapeutic hypothermia is a predictor of inhospital mortality after cardiac arrest, independent of injury severity and mean blood glucose levels.

[1]  Bart De Moor,et al.  Towards closed-loop glycaemic control. , 2009, Best practice & research. Clinical anaesthesiology.

[2]  F. Kuntschen,et al.  Glucose-insulin interactions during cardiopulmonary bypass. Hypothermia versus normothermia. , 1986, The Journal of thoracic and cardiovascular surgery.

[3]  H. Aso,et al.  Effects of cold exposure on insulin and glucagon secretion in sheep. , 1982, Endocrinology.

[4]  Stanley Lemeshow,et al.  Glucose variability and mortality in patients with sepsis* , 2008, Critical care medicine.

[5]  J. Krinsley,et al.  Glycemic variability: A strong independent predictor of mortality in critically ill patients* , 2008, Critical care medicine.

[6]  M. Schaller,et al.  Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome , 2006 .

[7]  W. Blackard,et al.  Insulin secretion in hypothermic dogs. , 1967, The American journal of physiology.

[8]  K. Polderman,et al.  Mechanisms of action, physiological effects, and complications of hypothermia , 2009, Critical care medicine.

[9]  J. Krinsley.  Glycemic variability in critical illness and the end of Chapter 1. , 2010, Critical care medicine.

[10]  M. Schaller,et al.  From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest. , 2006, Critical care medicine.

[11]  K. Maher,et al.  Continuous glucose monitors prove highly accurate in critically ill children , 2010, Critical care.

[12]  J. Hans DeVries,et al.  Glucose variability is associated with intensive care unit mortality* , 2010, Critical care medicine.

[13]  M. Schaller,et al.  Early predictors of outcome in comatose survivors of ventricular fibrillation and non-ventricular fibrillation cardiac arrest treated with hypothermia: A prospective study* , 2008, Critical care medicine.

[14]  R. Neumar,et al.  Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[15]  D. M. Keenan,et al.  Dynamic characteristics of blood glucose time series during the course of critical illness: Effects of intensive insulin therapy and relative association with mortality* , 2010, Critical care medicine.

[16]  B. Sutter,et al.  Effect of low temperatures on glucose-induced insulin secretion and glucose metabolism in isolated pancreatic islets of the rat. , 1990, The Journal of endocrinology.

[17]  Aha.  2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care , 2005 .

[18]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[19]  J. Lehot,et al.  Glucose homeostasis. Comparison between hypothermic and normothermic cardiopulmonary bypass. , 1992, Chest.

[20]  George Tomlinson,et al.  Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest. , 2004, JAMA.

[21]  Michael Holzer,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest , 2002 .

[22]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[23]  J. Steffen.  Glucose, glycogen, and insulin responses in the hypothermic rat. , 1988, Cryobiology.

[24]  Teresa Honrubia,et al.  Differences in complexity of glycemic profile in survivors and nonsurvivors in an intensive care unit: A pilot study* , 2010, Critical care medicine.

[25]  K. Sunde,et al.  Scandinavian Clinical practice guidelines for therapeutic hypothermia and post‐resuscitation care after cardiac arrest , 2009, Acta anaesthesiologica Scandinavica.

[26]  G. Reach,et al.  Glucagon and insulin secretion and their biological activities in hypothermic rats. , 1984, Endocrinology.

[27]  Karen Smith,et al.  Treatment of Comatose Survivors of Out-of-hospital Cardiac Arrest With Induced Hypothermia , 2003 .

[28]  J. Vincent.  Blood glucose control in 2010: 110 to 150 mg/dL and minimal variability. , 2010, Critical care medicine.

[29]  B. Sutter,et al.  Effect of low temperatures on glucose-induced insulin secretion and ionic fluxes in rat pancreatic islets. , 1987, The Journal of endocrinology.

[30]  R. Bellomo,et al.  Circadian rhythm of blood glucose values in critically ill patients , 2007, Critical care medicine.

[31]  Ingeborg H. F. Herold,et al.  Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods* , 2009, Critical care medicine.

[32]  P. Maćkowiak,et al.  Effect of hypothermia on insulin-receptor interaction in different rat tissues. , 2002, Physiological research.

[33]  P. Steen,et al.  In-hospital factors associated with improved outcome after out-of-hospital cardiac arrest. A comparison between four regions in Norway. , 2003, Resuscitation.

[34]  J. Soar,et al.  Postresuscitation care: entering a new era , 2010, Current opinion in critical care.

[35]  Alan D. Lopez,et al.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. , 2002, The New England journal of medicine.

[36]  R. Neumar,et al.  Consensus Process , 2022 .

[37]  G. Damante,et al.  Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. , 2001, American journal of physiology. Endocrinology and metabolism.

[38]  Antonio Ceriello,et al.  Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.

[39]  Michael Bailey,et al.  Blood glucose concentration and outcome of critical illness: The impact of diabetes* , 2008, Critical care medicine.

[40]  H. Chandalia,et al.  STRESS HYPERGLYCAEMIA , 1984, The Lancet.

[41]  Rinaldo Bellomo,et al.  Is reducing variability of blood glucose the real but hidden target of intensive insulin therapy? , 2009, Critical care.

[42]  Mauro Oddo,et al.  Prognostication after cardiac arrest and hypothermia: A prospective study , 2010, Annals of neurology.

[43]  J. Vincent,et al.  Critical illness-induced dysglycaemia: diabetes and beyond , 2010, Critical care.

[44]  R. Kawamori,et al.  Glucose fluctuation on the progression of diabetic macroangiopathy--new findings from monocyte adhesion to endothelial cells. , 2007, Diabetes research and clinical practice.

[45]  P. Kaplan,et al.  Prognostic value of continuous EEG monitoring during therapeutic hypothermia after cardiac arrest , 2010, Critical care.